2025质谱大会：SCIEX发布重磅新品

Core Insights - SCIEX launched the high-resolution mass spectrometry system ZenoTOF 8600 and announced the localization of the Triple Quad™ 7500+ production, marking a significant step in advancing precision medicine and biopharmaceutical development in China [1][2]. Product Highlights - The ZenoTOF 8600 became the focal point of the conference, showcasing significant improvements in sensitivity, scanning speed, and fragmentation modes [3][5]. - Sensitivity increased by tenfold compared to the previous generation, achieved through optimizations in components like the OptiFlow Pro ion source and Mass Guard/D-Jet ion transmission system [5][6]. - Scanning speed enhancements include the ZT Scan DIA 2.0, which can reach up to 858 Hz, allowing for more secondary spectra to aid in large sample analyses [5][6]. - The system features dual fragmentation modes: Electron Activation Dissociation (EAD) and Collision-Induced Dissociation (CID), enabling simultaneous acquisition of different secondary spectra [6]. Localization Strategy - SCIEX's localization strategy has progressed since establishing its first local production line in Suzhou in 2023, with the Triple Quad™ 7500+ now officially produced in China [8]. - This move reflects SCIEX's long-term commitment to the Chinese market and aims to integrate global technology with local high-end manufacturing capabilities [8][9]. - Local production enhances supply chain responsiveness and customer service efficiency while reducing overall usage costs, making advanced mass spectrometry technology more accessible across various applications [8]. Market Positioning - SCIEX's dual strategy of "global technology introduction" and "local high-end manufacturing" is reshaping the mass spectrometry market in China [9][11]. - The company’s advancements with the ZenoTOF 8600 and the localization of the Triple Quad™ 7500+ reaffirm its leading position and strategic focus in the Chinese mass spectrometry market [11].